Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.460
+0.020 (0.82%)
Nov 25, 2025, 4:00 PM EST - Market closed
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $938.88 million as of November 26, 2025. Its market cap has increased by 19.22% in one year.
Market Cap
938.88M
Enterprise Value
175.95M
1-Year Change
19.22%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $938.88M, a decrease of -17.50%. That is a compound annual growth rate of -2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 934.30M | 20.99% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |